Back
Aclaris Therapeutics Vs. MicroSectors™ FANG+™ 3X Leveraged ETN Industry Stock Comparison
Sell
20
ACRS
Aclaris Therapeutics
Last Price:
1.36
Seasonality Move:
4.39%
Buy
67
FNGU
MicroSectors™ FANG+™ 3X Leveraged ETN
Last Price:
319.52
Seasonality Move:
35.11%
Sell
20
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.30. The Score for ACRS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
67
MicroSectors™ FANG+™ 3X Leveraged ETN (FNGU)
is a Buy
Is MicroSectors™ FANG+™ 3X Leveraged ETN a Buy, Sell or Hold?
- The current MicroSectors™ FANG+™ 3X Leveraged ETN [FNGU] share price is $299.94. The Score for FNGU is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- FNGU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FNGU Stock Price Chart
What is MicroSectors™ FANG+™ 3X Leveraged ETN's stock price today?
-
The MicroSectors™ FANG+™ 3X Leveraged ETN share price today is $299.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNGU is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 62.13 | Buy |
| Chaikin Money Flow: | 587538 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.25) | Buy |
| Bollinger Bands (100): | (1.07 - 1.27) | Buy |
FNGU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.94 | Sell |
| Relative Strength Index (14 RSI): | 48.71 | Sell |
| Chaikin Money Flow: | 726421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (284.73 - 332.27) | Sell |
| Bollinger Bands (100): | (243.31 - 329.31) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.22 | Buy |
| 20-day SMA: | 1.22 | Buy |
| 50-day SMA: | 1.22 | Buy |
| 200-day SMA: | 3.58 | Sell |
| 8-day EMA: | 1.24 | Buy |
| 20-day EMA: | 1.22 | Buy |
| 50-day EMA: | 1.25 | Buy |
| 200-day EMA: | 3.53 | Sell |
FNGU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 293.58 | Buy |
| 20-day SMA: | 304.26 | Sell |
| 50-day SMA: | 316.75 | Sell |
| 200-day SMA: | 230.08 | Buy |
| 8-day EMA: | 295.17 | Buy |
| 20-day EMA: | 301.11 | Sell |
| 50-day EMA: | 303.31 | Sell |
| 200-day EMA: | 243.19 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
MicroSectors™ FANG+™ 3X Leveraged ETN Earnings Growth & FNGU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aclaris Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MicroSectors™ FANG+™ 3X Leveraged ETN Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||